Legend Biotech Corp. (LEGN)
34.86
+1.37
(+4.09%)
USD |
NASDAQ |
Jun 10, 16:00
34.85
-0.01
(-0.03%)
After-Hours: 04:21
Legend Biotech Market Cap : 6.475B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 6.475B |
| June 09, 2026 | 6.220B |
| June 08, 2026 | 5.855B |
| June 05, 2026 | 6.059B |
| June 04, 2026 | 6.352B |
| June 03, 2026 | 6.683B |
| June 02, 2026 | 6.739B |
| June 01, 2026 | 4.738B |
| May 29, 2026 | 5.045B |
| May 28, 2026 | 5.249B |
| May 27, 2026 | 5.260B |
| May 26, 2026 | 5.450B |
| May 22, 2026 | 5.421B |
| May 21, 2026 | 5.166B |
| May 20, 2026 | 5.190B |
| May 19, 2026 | 4.972B |
| May 18, 2026 | 4.980B |
| May 15, 2026 | 5.085B |
| May 14, 2026 | 5.279B |
| May 13, 2026 | 5.292B |
| May 12, 2026 | 5.216B |
| May 11, 2026 | 4.721B |
| May 08, 2026 | 5.190B |
| May 07, 2026 | 5.273B |
| May 06, 2026 | 5.345B |
| Date | Value |
|---|---|
| May 05, 2026 | 5.262B |
| May 04, 2026 | 4.891B |
| May 01, 2026 | 4.354B |
| April 30, 2026 | 4.341B |
| April 29, 2026 | 4.203B |
| April 28, 2026 | 4.348B |
| April 27, 2026 | 4.365B |
| April 24, 2026 | 4.411B |
| April 23, 2026 | 4.428B |
| April 22, 2026 | 4.786B |
| April 21, 2026 | 4.655B |
| April 20, 2026 | 4.627B |
| April 17, 2026 | 3.907B |
| April 16, 2026 | 3.891B |
| April 15, 2026 | 3.787B |
| April 14, 2026 | 3.450B |
| April 13, 2026 | 3.265B |
| April 10, 2026 | 3.352B |
| April 09, 2026 | 3.359B |
| April 08, 2026 | 3.378B |
| April 07, 2026 | 3.320B |
| April 06, 2026 | 3.448B |
| April 02, 2026 | 3.533B |
| April 01, 2026 | 3.516B |
| March 31, 2026 | 3.339B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Protagonist Therapeutics, Inc. | 6.793B |
| AbbVie, Inc. | 397.43B |
| Capricor Therapeutics, Inc. | 1.461B |
| Viking Therapeutics, Inc. | 3.216B |
| Arcutis Biotherapeutics, Inc. | 2.905B |
Market Cap Related Metrics
| PS Ratio | 5.636 |
| PEG Ratio | -1.786 |
| Price to Book Value | 6.691 |
| Price | 34.86 |
| Earnings Yield | -3.90% |
| PEGY Ratio | -1.786 |